Joshua J Field, MD, MS | Medical College of Wisconsin

Joshua J. Field, MD, MS

Professor

view physician profile

Locations

Froedtert Hospital
Children's Wisconsin - Milwaukee
Children's Wisconsin Clinics - Milwaukee
Cancer Center - Moorland Reserve Health Center

Specialties

Hematology

Languages

English

Education

MD - Doctor of Medicine
MS

Biography

Dr. Joshua Field is an Associate Professor of Medicine in the Division of Hematology and Oncology at the Medical College of Wisconsin. He is also serving as Section Chief of Benign Hematology and Medical Director of the Sickle Cell Clinic in the Froedtert Hospital. Dr. Field specializes in the treatment of sickle cell disease and other benign hematological disorders at Froedtert Hospital Dr. Field graduated medical school from the University of Iowa. He completed an internal medicine residency and fellowships in hematology and transfusion medicine at Washington University in St. Louis, where he was chief resident in internal medicine and chief fellow in hematology and oncology.

Dr. Field is also serving as Senior Medical Director and Senior Investigator in Versiti.

Research Interests

Dr. Field is board certified in transfusion medicine and hematology. He conducts clinical and translational research studies in adults with sickle cell disease.

Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.

(Kuter DJ, Rogers KA, Boxer MA, Choi M, Agajanian R, Arnold DM, Broome CM, Field JJ, Murakhovskaya I, Numerof R, Tong S.) Am J Hematol. 2022 06 01;97(6):691-699 PMID: 35179251 SCOPUS ID: 2-s2.0-85125529424 02/19/2022
Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry.

(Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators.) Br J Haematol. 2021 12;195(5):e157-e160 PMID: 34423416 SCOPUS ID: 2-s2.0-85113314912 08/24/2021
Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.

(Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C Jr, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R.) Ann Intern Med. 2021 09;174(9):1207-1213 PMID: 34224261 SCOPUS ID: 2-s2.0-85117425920 07/06/2021
Chronic Pain Does Not Impact Baseline Circulating Cytokine Levels in Adults with Sickle Cell Disease.

(Karafin MS, Simpson P, Field JJ.) Acta Haematol. 2021;144(1):111-116 PMID: 32403100 SCOPUS ID: 2-s2.0-85085034465 05/14/2020
Social and Psychological Factors Associated With Health Care Transition for Young Adults Living With Sickle Cell Disease.

(Clayton-Jones D, Matthie N, Treadwell M, Field JJ, Mager A, Sawdy R, George Dalmida S, Leonard C, Koch KL, Haglund K.) J Transcult Nurs. 2021 01;32(1):21-29 PMID: 31889479 SCOPUS ID: 2-s2.0-85077517948 01/01/2020
Circulating fibrocytes as prognostic biomarkers of autoimmune interstitial lung disease.

(Odackal J, Yu V, Gomez-Manjerres D, Field JJ, Burdick MD, Mehrad B.) ERJ Open Res. 2020 Oct;6(4) PMID: 33263049 PMCID: PMC7682700 12/03/2020
Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

(Field JJ, Kassim A, Brandow A, Embury SH, Matsui N, Wilkerson K, Bryant V, Zhang L, Simpson P, DeBaun MR.) Blood Adv. 2020 03 24;4(6):1159-1165 PMID: 32208487 PMCID: PMC7094028 SCOPUS ID: 2-s2.0-85082514389 03/26/2020
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

(Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA.) Blood Adv. 2020 Jan 28;4(2):327-355 PMID: 31985807 PMCID: PMC6988392 SCOPUS ID: 2-s2.0-85083898038 01/28/2020
Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL).

(Wright N, Voshtina E, George G, Singavi A, Field J.) Int J Hematol. 2019 Dec;110(6):751-755 PMID: 31494832 SCOPUS ID: 2-s2.0-85071870349 09/09/2019
The controversial role of red cell transfusions for sickle cell pain.

(Karafin MS, Field JJ.) Curr Opin Hematol. 2019 11;26(6):442-447 PMID: 31567433 SCOPUS ID: 2-s2.0-85072300896 10/01/2019
Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report.

(Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES.) Ann Am Thorac Soc. 2019 09;16(9):e17-e32 PMID: 31469310 PMCID: PMC6812163 SCOPUS ID: 2-s2.0-85071755388 08/31/2019
Chronic pain persists in adults with sickle cell disease despite regular red cell transfusions.

(Karafin MS, Mullins DE, Johnson ST, Nischik D, Feng M, Simpson P, Field JJ.) Transfus Apher Sci. 2019 Aug;58(4):434-438 PMID: 31326289 SCOPUS ID: 2-s2.0-85068968608 07/22/2019